Platelet Refractoriness during BONE Marrow Transplantation, Comparison in Aplasticanemia and Beta Thalassemia Major Patients.an Experience of Public Sector BMT Unit in Pakistan
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.522
Abstract: Background Bone Marrow Transplantation (BMT) is curative treatment modality for many Hematological and oncological diseases. This treatment is commonly available in developed countries but Lower middle income countries (LMICs) like Pakistan this facility is not… read more here.
Keywords: marrow transplantation; platelet refractoriness; bmt; beta thalassemia ... See more keywords
Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
Sign Up to like & getrecommendations! Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2021.280493
Abstract: Approximately 20% of patients receiving multiple platelet transfusions develop platelet alloantibodies, which can be directed against human leukocyte antigens (HLA) and, to a lesser extent, against human platelet antigens (HPA). These antibodies can lead to… read more here.
Keywords: complement activation; anti hla; platelet refractoriness; platelet ... See more keywords